Atrium Therapeutics (RNA) Q4 2025 Earnings

Nov 10Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.27
-1.11
-0.95
-0.79

Details

Expected EPS
-1.085268
Actual EPS
-1.27
Surprise EPS
-0.18
Surprise Percent
-17.02%

Description

⁨Atrium Therapeutics⁩ (⁦RNA⁩) has reported earnings of ⁦-1.27⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts